Page last updated: 2024-12-05

amylocaine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Amylocaine is a local anesthetic that was originally synthesized in 1917. It is a white crystalline powder that is soluble in water and alcohol. It is used in dentistry, ophthalmology, and other medical fields to provide local anesthesia. Amylocaine is a potent local anesthetic that is effective at blocking pain and other sensations. It is also relatively safe and well-tolerated by most patients. Amylocaine is studied because it is a valuable tool for pain management. It is also studied because it can be used to treat a variety of conditions, including chronic pain, nerve pain, and pain from surgery.'

amylocaine: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10767
CHEMBL ID1740065
CHEBI ID34981
SCHEMBL ID81360
MeSH IDM0065148

Synonyms (44)

Synonym
BRD-A09062839-003-03-5
amyleine
2-butanol, 1-(dimethylamino)-2-methyl-, benzoate
1-(dimethylamino)-2-methyl-2-butanol benzoate
2-butanol, 1-(dimethylamino)-2-methyl-, benzoate (ester)
1-(dimethylaminomethyl)-1-methylpropyl benzoate
einecs 211-411-1
1-((dimethylamino)methyl)-1-methylpropyl benzoate
brn 2453568
amylocaine [ban]
stovaine
amylocaine
644-26-8
BSPBIO_000177
BPBIO1_000195
NCGC00179641-01
D07454
amylocaine (ban)
PRESTWICK2_000049
PRESTWICK3_000049
PRESTWICK0_000049
SPBIO_002098
PRESTWICK1_000049
[1-(dimethylamino)-2-methylbutan-2-yl] benzoate
chebi:34981 ,
CHEMBL1740065
4-09-00-00566 (beilstein handbook reference)
qrw683o56t ,
unii-qrw683o56t
amylocaine [mi]
amylocaine [who-dd]
SCHEMBL81360
stovine
FDMBBCOBEAVDAO-UHFFFAOYSA-N
1-[(dimethylamino)methyl]-1-methylpropyl benzoate #
DTXSID6047862
[1-[(dimethylamino)methyl]-1-methyl-propyl] benzoate
DB09088
1-[(dimethylamino)methyl]-1-methylpropyl benzoate
Q1641923
CS-0613907
HY-148157
1-(dimethylamino)-2-methylbutan-2-yl benzoate
EN300-18562915
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
benzoate esterEsters of benzoic acid or substituted benzoic acids.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (50.00)18.7374
1990's2 (12.50)18.2507
2000's3 (18.75)29.6817
2010's3 (18.75)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 33.51

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index33.51 (24.57)
Research Supply Index3.14 (2.92)
Research Growth Index4.47 (4.65)
Search Engine Demand Index40.78 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (33.51)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies3 (13.64%)4.05%
Observational1 (4.55%)0.25%
Other18 (81.82%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]